Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Sensible Medical

Sensible Medical

Sensible Medical Innovations has set out to develop a new standard of care in lung fluid management. Sensible developed the ReDS™ medical radar technology that stems from defense "see through wall" applications. The technology is well positioned to be a game changer in a wide range of applications, and become the next generation monitoring and imaging modality. Sensible Medical Innovations received FDA 510(k) clearance and CE mark for ReDS™ System, its non-invasive thoracic fluid status monitor. The product is intended for use by qualified health care practitioners and by patients, under the direction of a physician, in hospitals, hospital-type facilities and home environment, for the non-invasive monitoring and management of patients with fluid management problems in a variety of medically accepted clinical applications. ReDS is indicated for patients with fluid management problems, taking diuretic medication, living with Heart Failure, or recovering from Coronary Artery Disease related event.

Last updated on

About Sensible Medical

Founded

2007

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$20M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Location

City

Netanya

State

Central District

Country

Israel
Sensible Medical

Sensible Medical

Find your buyer within Sensible Medical

Tech Stack (78)

search